Reaction Details Report a problem with these data
Target
Monoglyceride lipase
Ligand
BDBM581518
Substrate
n/a
Meas. Tech.
Biological Assay
IC50
0.088±n/a nM
Citation
 Alcazar, J; Ameriks, MK; Berry, CB; Garcia-Reynaga, P; Samant, AV; Vega-Ramiro, JA Azaspirocycles as monoacylglycerol lipase modulators US Patent  US11505546 Publication Date 11/22/2022 
Target
Name:
Monoglyceride lipase
Synonyms:
HU-K5 | Lysophospholipase homolog | Lysophospholipase-like | MAGL | MGL | MGLL | MGLL_HUMAN
Type:
Hydrolase
Mol. Mass.:
33264.56
Organism:
Homo sapiens (Human)
Description:
Human recombinant MGL (Cayman Chemical, cat# 10008354).
Residue:
303
Sequence:
MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
  
Inhibitor
Name:
BDBM581518
Synonyms:
(2s,4s)-2-[2-(3-Cyclopropylphenyl)-7-azaspiro[3.5]nonane-7-carbonyl)-7-oxa-5- azaspiro[3.4]octan-6-one | US11505546, Example 5
Type:
Small organic molecule
Emp. Form.:
C24H30N2O3
Mol. Mass.:
394.5066
SMILES:
O=C([C@H]1C[C@@]2(C1)COC(=O)N2)N1CCC2(CC(C2)c2cccc(c2)C2CC2)CC1 |r,wU:2.1,wD:4.4,(-2.84,4.01,;-2.84,2.47,;-4.18,1.7,;-4.57,.21,;-6.06,.61,;-5.66,2.1,;-6.06,-.93,;-7.53,-1.41,;-8.43,-.16,;-9.92,.24,;-7.53,1.09,;-1.51,1.7,;-1.51,.16,;-.18,-.61,;1.16,.16,;1.56,-1.33,;3.04,-.93,;2.65,.56,;4.38,-1.7,;4.38,-3.24,;5.71,-4.01,;7.05,-3.24,;7.05,-1.7,;5.71,-.93,;8.38,-.93,;9.92,-.93,;9.15,.4,;1.16,1.7,;-.18,2.47,)|
Structure:
Search PDB for entries with ligand similarity: